Status:
TERMINATED
Prenatal Molecular Characterisation by CGH+SNP-ARRAY of Supernumerary Marker Chromosomes and de Novo Apparently Balanced Reciprocal Translocations
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Pre-natal Patient
Eligibility:
All Genders
Phase:
NA
Brief Summary
In the prenatal period, les supernumerary marker chromosomes (SMC) and de novo apparently balanced reciprocal translocations are revealed by foetal karyotyping, which does not always make it possible ...
Eligibility Criteria
Inclusion
- Metaphase karyotyping with SMC or a de novo Apparently-balanced reciprocal translocation
- Parents covered by the National Health Insurance Agency,
- Consent of the parents
Exclusion
- Persons not covered by the National Health Insurance Agency
- Normal foetal karyotyping or showing chromosomal anomalies not related to the present study (trisomy 18….) or inherited anomalies
- Absence of a sample from one of the parents
Key Trial Info
Start Date :
August 30 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01907425
Start Date
August 30 2013
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Dijon
Dijon, France, 21079